Cindy Tan

---

Cindy Tan is in Lincoln High School's Class of 2026, where she exhibits interest in biochemistry. Motivated by a passion for advancing medical research and technology, she took part in DREAM-High's 2025 summer program to explore the interconnection between systems biology and computational science. From this experience, she has learned introductory level R programming, which she aims to develop through personal projects. At the same time, she worked as a product management intern at MaximalLearning, where she applied her analytical skills to cater features for students in transition to college. Beyond STEM, she is an active leader at OneWorld Now!, where she works to foster cultural inclusivity and youth empowerment. Cindy aspires to combine her interests in research, technology, and leadership to contribute advancements within healthcare and biotechnology. 

Through hands-on programming, DREAM-High Scholars visualize and analyze genomics, clinical, and physical data from breast cancer cells. DREAM-High is a partnership between the Columbia Center for Cancer Systems Therapeutics, the Palazzo Strozzi Foundation USA, the Stanford Center for Cancer Systems Biology, and the Institute for Systems Biology. 

In the DREAM-High program, Scholars learn to program in R, a language for statistical computing and graphics. They manipulate and write code in a cloud-based RStudio environment to analyze a wide range of data on breast cancer patients and cancer cell lines. 

I created heat maps as colorized representations of data matrices. I reordered features and observations so that similar entities are close to each other in the graph.  Heat maps make it easy to visualize and understand complex data.

I loaded and examined a data frame of clinical information from 1,082 breast cancer patients from The Cancer Genome Atlas (TCGA). I summarized clinical measurements on both the patients, such as  gender and age, and the patients’ tumors, such as estrogen receptor status and histology.

I performed an integrative analysis of clinical measurements and gene expression data for 1,082 patients in the TCGA Breast Cancer cohort. By calculating heat maps and annotating them with clinical information, I detected patterns in the patients' expression profiles across 18,351 genes that correspond to luminal and triple negative breast cancers.

I discovered biological processes that distinguish cancer cell lines based on the aggressiveness of the cancers they model. For both breast cancer and colon cancer cell lines, I calculated, visualized, and functionally annotated differential gene expression profiles with data from the Physical Sciences in Oncology Cell Line Characterization Study.

I built linear regression models that are predictive of breast cancer survival from the METABRIC breast cancer dataset. I found that gene expression profiles of certain cancer genes are predictive of prognosis. Inclusion of additional features in my model increased its explanatory power.